Physician profile
Elizabeth M Devader
NPI 1427748722
$1,593.40
in general payments reported to CMS, 2019-2025
11 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $713 · 2024: $488 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,561.13 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $485.73 | 2023-2024 | Gvoke Hypopen |
| Novo Nordisk INC | $292.47 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Insulet Corporation | $284.06 | 2024-2025 | Omnipod |
| Averitas Pharma INC. | $123.34 | 2023 | Qutenza |
| Corcept Therapeutics | $110.00 | 2023 | Korlym |
| Amgen INC. | $97.36 | 2024 | Tepezza |
| Ascensia Diabetes Care US INC. | $77.61 | 2023 | |
| Sanofi-Aventis U.S. LLC | $41.47 | 2024 | |
| Tandem Diabetes Care, INC. | $35.65 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $26.07 | 2025 | Twiist |
| Takeda Pharmaceuticals U.S.A., INC. | $19.64 | 2024 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Devader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.